November 19, 2011
by admin
1 Comment
Choosing the right path in clinical development – as in life – is a huge challenge. For small companies it can be the difference between success and failure, survival and implosion. But divergent clinical data published in the last month … Continue reading
November 1, 2011
by admin
0 comments
For a decade investors in the development of therapeutic products have been coming to terms with the shrinking market sizes of approved products. The focus today is on avoiding “busters” (drugs that are registered, but never achieve any meaningful sales) … Continue reading